Booster COVID-19 jabs will be offered to people aged 50 and over, those in care homes, and frontline health and social care workers, the British government announced Tuesday.
A new study has revealed that the side effects of the Pfizer-BioNTech jab against COVID-19 in 12-15-year-olds at high risk of complications from the infection are likely to be mild to moderate and clear up quickly because of certain coexisting conditions.
